What Does Pharmaceutical 3D Printing Cost? A Framework and Case Study with Hydrocortisone for Adrenal Insufficiency
Manufacturing costs of 3D-printed pharmaceuticals were thus far unknown. The framework is translated into an open-access costing tool to facilitate adoption by other parties, and is also applicable for other pharmaceutical 3DP techniques.
Authors
- Hugo van der Kuy
- Elisabeth J. Ruijgrok (ORCID: https://orcid.org/0000-0003-2137-5525)
- Renske M.T. ten Ham (ORCID: https://orcid.org/0000-0002-2638-8045)
- Frederick W. Thielen (ORCID: https://orcid.org/0000-0002-0312-5891)
- Sejad Ayyoubi (ORCID: https://orcid.org/0000-0002-6251-2517)
Institutions
- Erasmus MC (NL)
- University Medical Center Utrecht (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- PharmacoEconomics - Open
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1007/s41669-024-00551-1
- Citations
- 7
- Primary Topic
- 3D Printing in Biomedical Research
- Type
- article
- Field-Weighted Citation Impact
- 1.29